1. Home
  2. GNLX
  3. GNLX News

Latest Genelux Corporation (GNLX) News on April 2, 2025

Genelux doses first subject in Phase II trial of NSCLC treatment

Clinical Trials Arena

5 months ago

Genelux doses first subject in Phase II trial of NSCLC treatment

0246810AI: Highly Positive
Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?

Simply Wall St.

8 months ago

Is Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?

0246810AI: Slightly Positive
Genelux Corporation (GNLX): A Strong Buy According to Hedge Funds

Insider Monkey

8 months ago

Genelux Corporation (GNLX): A Strong Buy According to Hedge Funds

0246810AI: Slightly Positive

MT Newswires

10 months ago

Top Midday Decliners

0246810AI: Neutral

MT Newswires

10 months ago

Top Premarket Gainers

0246810AI: Highly Positive

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use